Cheap Drugs Have A High Cost: The Safety Issues Of Generic Prescriptions
Our expert discusses the steps needed to keep consumers safe.


Our expert discusses the steps needed to keep consumers safe.

Not all generic drugs are created equal. How much of a benefit do you get from learning a second language? A new product to help stop the spread of malaria. Your next hospital visit may look a bit greener.

Our expert explains the systems in place – as well as their weaknesses and strengths.

Our experts explain the effects of this ongoing shortage and how we can make sure it doesn’t happen again.

According to Georgetown University’s Health Policy Institute, 66% of all U.S. adults use prescription drugs – and a majority of those are generic. So why don’t we know where these products are made?

Since the Covid-19 pandemic began, public health experts have looked to vaccines with the goal of creating “herd immunity.” Now it is clear we will not reach that goal. One of the nation’s leading infectious disease experts discusses how we are missing the target and what it means.

Since the 1980’s, almost all production of generic drugs has moved overseas, where FDA inspectors have a much tougher time making sure they’re following rules for safety. An investigative journalist describes the ways she’s found that many drugmakers cut corners, putting safety at risk, and details what consumers can do to protect themselves.

Millions of Americans cannot afford the medications they’ve been prescribed. Many skip doses, split pills or don’t fill prescriptions at all as a result, with sometimes even fatal consequences. Experts discuss the problem and what patients can do to save.

People suffering from mental illnesses often go through a number of medications before they find one that works. A genetic test seeks to discover this information right away, so patients don’t have to wait. One of the test’s developers discusses its uses.

Since the 1980’s, almost all production of generic drugs has moved overseas, where FDA inspectors have a much tougher time making sure they’re following rules for safety. An investigative journalist describes the ways she’s found that many drugmakers cut corners, putting safety at risk, and details what consumers can do to protect themselves.

Reed Pence speaks with investigative Reporter Katherine Eband, author of Bottle of Lies: The Inside Story of the Generic Drug Boom about the quality of regulation of generic drugs.

Explorers and scientists are speculating that an age inhibitor, or "fountain of youth" drug may be ready for human trials. Lower speed limits increase crashes due to government overrides? A study suggesting, "Let's do science" is much more effective at getting girls engaged than suggesting, "Let's be scientists."
Subscribe to get the latest from Radio Health Journal directly in your inbox.

